The global cardiovascular health supplements market size in 2026 is witnessing steady growth as consumers increasingly focus on preventive heart care, healthy aging, and overall cardiovascular wellness. According to Fortune Business Insights, the global cardiovascular health supplements market size was valued at USD 12.31 billion in 2025. The market is projected to grow from USD 13.00 billion in 2026 to USD 21.55 billion by 2034, exhibiting a CAGR of 6.52% during the forecast period. North America dominated the market with a 41.02% share in 2025.
Cardiovascular health supplements include nutritional products formulated around ingredients such as omega-3 fatty acids, vitamins, minerals, Coenzyme Q10, plant sterols and stanols, botanical ingredients, amino acids, and soluble fibers. These products are positioned for benefits including cholesterol and triglyceride management, blood pressure support, circulation and vascular support, heart function, and general cardiovascular wellness. Manufacturers are increasingly emphasizing scientifically supported ingredients, combination formulations, clean-label positioning, and convenient dosage formats to improve consumer acceptance.
The rising burden of cardiovascular diseases and the growth of the aging population are key factors supporting market expansion. Increasing awareness of preventive healthcare and self-managed heart wellness is encouraging consumers to incorporate cardiovascular health supplements into daily routines. Risk factors associated with cardiovascular conditions, including unhealthy diets, physical inactivity, obesity, high blood pressure, elevated blood glucose, and raised blood lipid levels, are contributing to demand for targeted nutritional formulations. Manufacturers are responding with products designed around cholesterol management, circulation, vascular support, and general cardiovascular wellness.
Innovation in clinically supported multi-ingredient and personalized formulations is another important growth factor. Expansion of e-commerce, pharmacy networks, omnichannel distribution, plant-based ingredients, clean-label products, and convenient supplement formats is also supporting market development. At the same time, the increasing availability of counterfeit, adulterated, and misleadingly marketed supplements is creating challenges. Regulatory variability, restricted health claims, inconsistent clinical evidence, and the comparatively high cost of premium and clinically validated formulations may also restrict growth.
The global cardiovascular health supplements market is moderately fragmented, with multinational consumer-health companies competing with specialized omega-3, CoQ10, botanical, vitamin, mineral, and direct-selling brands. Leading companies are strengthening their positions through product launches, ingredient-delivery technologies, retail expansion, strategic partnerships, and direct-to-consumer channels. Established companies benefit from recognized brands, extensive pharmacy and retail networks, manufacturing capabilities, quality-control systems, and international distribution.